The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blo

[1]  Z. Han,et al.  Ex vivo expansion of megakaryocytic cells. , 2000, International journal of hematology.

[2]  E..  Modulation of Megakaryocytopoiesis by Thrombopoietin : The c-Mpl Ligand , 2000 .

[3]  W. Holzgreve,et al.  Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. , 1999, Experimental hematology.

[4]  V. Diehl,et al.  Using at least 5×106/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation , 1999, Bone Marrow Transplantation.

[5]  W. Piacibello,et al.  Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. , 1999, Blood.

[6]  J. Liu,et al.  Ex vivo expansion of enriched CD34+ cells from neonatal blood in the presence of thrombopoietin, a comparison with cord blood and bone marrow , 1999, Bone Marrow Transplantation.

[7]  W. Piacibello,et al.  HEMATOPOIESIS Engraftment in Nonobese Diabetic Severe Combined Immunodeficient Mice of Human CD 34 1 Cord Blood Cells After Ex Vivo Expansion : Evidence for the Amplification and Self-Renewal of Repopulating Stem Cells , 1999 .

[8]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[9]  H. Snoeck,et al.  CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. , 1998, Experimental hematology.

[10]  W. Piacibello,et al.  Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation , 1998, Leukemia.

[11]  H. Miyazaki,et al.  Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin. , 1998, Experimental hematology.

[12]  S. Tura,et al.  Megakaryocyte progenitors derived from bone marrow or G‐CSF‐mobilized peripheral blood CD34+ cells show a distinct phenotype and responsiveness to interleukin‐3 (IL‐3) and PEG‐recombinant human megakaryocyte growth and development factor (PEG‐rHuMGDF) , 1998, British journal of haematology.

[13]  R. Czajka,et al.  A novel serum free system for cloning human megakaryocytic progenitors (CFU-Meg). The role of thrombopoietin and other cytokines on bone marrow and cord blood CFU-Meg growth under serum free conditions. , 1998, Folia histochemica et cytobiologica.

[14]  E. Shpall,et al.  Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. , 1997, Experimental hematology.

[15]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[16]  J. Dick,et al.  Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.

[17]  W. Piacibello,et al.  Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. , 1997, Blood.

[18]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[19]  M. Baiocchi,et al.  Circulating progenitor cells in human ontogenesis: response to growth factors and replating potential. , 1996, Journal of hematotherapy.

[20]  E. Dessypris,et al.  Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34+ cells in a serum‐free system , 1996, British journal of haematology.

[21]  Lesley J. Murray,et al.  Detection of a primitive megakaryocyte progenitor cell in human fetal bone marrow. , 1996, Experimental hematology.

[22]  H. Miyazaki,et al.  Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c‐mpl ligand) and the effects of gestational age on frequency of colonies , 1996, British journal of haematology.

[23]  G. Crooks,et al.  A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. , 1995, Blood.

[24]  L. Schwartzberg,et al.  An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. , 1995, Blood.

[25]  M. Cairo,et al.  IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. , 1995, Experimental hematology.

[26]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Gordon,et al.  Probability of progenitor renewal (PPR) and production of clonogenic progeny (CFU‐GM) by primitive adherent progenitor cells in adult human bone marrow and umbilical cord blood , 1995, British journal of haematology.

[28]  J. Wagner,et al.  Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease , 1995, The Lancet.

[29]  T. Kato,et al.  Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. , 1995, The Journal of clinical investigation.

[30]  S. Kosak,et al.  Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. , 1995, Blood.

[31]  M. Urashima,et al.  Effects of cytokines on hematopoietic progenitor cells in cord blood, in bone marrow, and in peripheral blood mobilized by chemotherapy and G‐CSF , 1995, Acta paediatrica Japonica : Overseas edition.

[32]  A. Nagler,et al.  The response of cord blood megakaryocyte progenitors to IL‐3, IL‐6 and aplastic canine serum varies with gestational age , 1995, British journal of haematology.

[33]  D. Bron,et al.  Comparison of the coexpression of cd38, cd33 and hla‐dr antigens on cd34+ purified cells from human cord blood and bone marrow , 1995, Stem cells.

[34]  M. Vitale,et al.  In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum‐free culture conditions , 1994, British journal of haematology.

[35]  W. Lee,et al.  Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. , 1994, Clinical immunology and immunopathology.

[36]  G. Tjønnfjord,et al.  Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. , 1994, Journal of hematotherapy.

[37]  W. Lee,et al.  Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. , 1994, Blood cells.

[38]  P. Lansdorp,et al.  Ontogeny-related changes in proliferative potential of human hematopoietic cells , 1993, The Journal of experimental medicine.

[39]  S. Capitani,et al.  Presence and Characteristics of Circulating Megakaryocyte Progenitor Cells in Human Fetal Blood , 1993 .

[40]  S. Capitani,et al.  Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood. , 1993, Blood.

[41]  J. Adamson,et al.  Long-term generation of colony-forming cells in liquid culture of CD34+ cord blood cells in the presence of recombinant human stem cell factor. , 1992, Blood.

[42]  L. To,et al.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.

[43]  J. Adamson,et al.  Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro , 1991, Journal of cellular physiology.

[44]  E. M. Smogorzewska,et al.  A Functional Comparison of CD 34 + CD 38-Cells in Cord Blood and Bone Marrow , 2022 .